— Know what they know.
Not Investment Advice

PURE OTC

PURE Bioscience, Inc.
1W: -11.3% 1M: +0.2% 3M: -5.2% YTD: +59.2% 1Y: -26.0% 3Y: -37.9% 5Y: -84.7%
$0.06
-0.00 (-4.46%)
 
Weekly Expected Move ±25.4%
$0 $0 $0 $0 $0
OTC · Basic Materials · Chemicals · Tech Score Sell · Power 39 · $8.1M mcap · 84M float · 0.037% daily turnover · Short 46% of daily vol

📊 Key Metrics

TTM
$2M
Revenue
+26.7% YoY
$-2M
Net Income
+21.9% YoY
$-2M
Free Cash Flow
+17.3% YoY
53.2%
Gross Margin
-102.4%
Op. Margin
-123.3%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE41.4%
ROA-168.6%
ROIC465.7%

Valuation

P/E-3.0
P/B-1.1
EV/EBITDA71.7

Leverage

Debt/Equity-1.11
Current Ratio0.42
Interest Cov.-0.0x

Quality Scores

Piotroski F5/9
Altman Z-129.86
Beneish M-3.73

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms